BRIDGEWATER, N.J., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today that John Timberlake, President and Chief Executive Officer and Erick Lucera, Chief Financial Officer are scheduled to present at the Canaccord Medical Technologies & Diagnostic Forum.
Audio webcasts of the Company's presentation will be available by visiting the investor relations section of the Valeritas website at www.valeritas.com. Replays of the presentation will be available for 90 days. About Valeritas Holdings, Inc.Valeritas is a commercial-stage medical technology company focused on developing innovative technologies to improve the health and quality of life of people with Type 2 diabetes. Valeritas' flagship product, V-Go ® Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for patients with Type 2 diabetes that enables patients to administer a continuous preset basal rate of insulin over 24 hours. It also provides on-demand bolus dosing at mealtimes. It is the only basal-bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type 2 diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R&D functions in a state-of-the-art facility in Shrewsbury, Massachusetts. For more information, please visit www.valeritas.com.
|Event:||Canaccord Medical Technologies & Diagnostic Forum|
|Format:||Presentation and One-on-One Meetings|
|Date:||Thursday, November 17, 2016|
|Location:||New York, NY|
Investor Contacts:Nick Laudico / Robert Flamm, Ph.D.The Ruth Group(646)536-7030 / 7017IR@valeritas.comOrThe Del Mar Consulting Group, Inc.Robert B. Prag, President858firstname.lastname@example.orgMedia Contact:Christopher HippolyteThe Ruth Group(646)536-7023PR@valeritas.com